Cargando…

Case Report: Unremitting COVID-19 Pneumonia, Viral Shedding, and Failure to Develop Anti-SARS-CoV-2 Antibodies for More Than 6 Months in Patient with Mantle Cell Lymphoma Treated with Rituximab

Severe cases of COVID-19 are being reported in patients with comorbidities and drug-induced immunosuppression. The risk seems to depend on the type of immunosuppressive agents used, and it is particularly high with rituximab because of its long-lasting effects. We report a 71-year-old man with COVID...

Descripción completa

Detalles Bibliográficos
Autores principales:	Berktas, Bahadir M., Koyuncu, Adem
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The American Society of Tropical Medicine and Hygiene 2022
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8991362/ https://www.ncbi.nlm.nih.gov/pubmed/35213815 http://dx.doi.org/10.4269/ajtmh.21-1010

Ejemplares similares

Childhood Depression with Unremitting Suicidal Behavior
por: Aravind, Vaithiyam Krishnaram, et al.
Publicado: (2010)

Neonatal Presentation of Unremitting Inflammatory Bowel Disease
por: Ebrahimi, Sara, et al.
Publicado: (2018)

Perianal infectious dermatitis: An underdiagnosed, unremitting and stubborn condition
por: Serban, Elena Daniela
Publicado: (2018)

Tuning cancer fate: the unremitting role of host immunity
por: Calì, B., et al.
Publicado: (2017)

Persistent Inpatient Harm: the Unremitting Challenge of Patient Safety
por: Adashi, Eli Y., et al.
Publicado: (2022)

Pituitary and SARS CoV-2: An unremitting conundrum
por: Capatina, Cristina, et al.
Publicado: (2023)

Rituximab retherapy in patients with relapsed aggressive B cell and mantle cell lymphoma
por: Borgerding, Andrea, et al.
Publicado: (2009)

Leuconostoc sp. Meningitis in a Patient Treated with Rituximab for Mantle Cell Lymphoma
por: Holik, Hrvoje, et al.
Publicado: (2015)

Gastrointestinal Perforation after Rituximab Therapy in Mantle Cell Lymphoma: A Case Report
por: Adashek, Michael, et al.
Publicado: (2018)

Atypical COVID-19 dynamics in a patient with mantle cell lymphoma exposed to rituximab
por: Marcacci, Gianpaolo, et al.
Publicado: (2021)

Adding venetoclax to lenalidomide and rituximab is safe and effective in patients with untreated mantle cell lymphoma
por: Phillips, Tycel J., et al.
Publicado: (2023)

Rituximab and Bendamustine (BR) Compared with Rituximab, Bendamustine, and Cytarabine (R-BAC) in Previously Untreated Elderly Patients with Mantle Cell Lymphoma
por: Bega, Giulia, et al.
Publicado: (2021)

Emerging evidence of occipital nerve compression in unremitting head and neck pain
por: Blake, Pamela, et al.
Publicado: (2019)

Unremitting chronic skin lesions: a case of delayed diagnosis of glucagonoma
por: Kawsar, Hameem I., et al.
Publicado: (2019)

Early Onset Neutropenia due to Rituximab Therapy in Mantle Cell Lymphoma: A Case Report
por: Nelson, Blessie Elizabeth, et al.
Publicado: (2021)

Bendamustine or high-dose cytarabine-based induction with rituximab in transplant-eligible mantle cell lymphoma
por: Villa, Diego, et al.
Publicado: (2022)

Rituximab/bendamustine/cytarabine for transplant‐eligible patients with mantle cell lymphoma: A retrospective study
por: Shimizu, Yuki, et al.
Publicado: (2023)

Nine-year follow-up of lenalidomide plus rituximab as initial treatment for mantle cell lymphoma
por: Yamshon, Samuel, et al.
Publicado: (2023)

An evaluation of the potential for drug–drug interactions between bendamustine and rituximab in indolent non-Hodgkin lymphoma and mantle cell lymphoma
por: Darwish, Mona, et al.
Publicado: (2014)

Understanding family functioning and social support in unremitting schizophrenia: A study in India
por: Sawant, Neena S., et al.
Publicado: (2010)

Periclase deforms more slowly than bridgmanite under mantle conditions
por: Cordier, Patrick, et al.
Publicado: (2023)

Sarcoid-Like Reaction in the Kidney Following Rituximab for Mantle Lymphoma in a 60-Year-Old Man
por: Mrabet, Sanda, et al.
Publicado: (2023)

The addition of rituximab to chemotherapy improves overall survival in mantle cell lymphoma—a pooled trials analysis
por: Fischer, Luca, et al.
Publicado: (2023)

Cyclophosphamide/fludarabine/rituximab: Prolonged viral shedding and protracted COVID-19: case report
Publicado: (2022)

Bendamustine/rituximab: Prolonged SARS-CoV-2 viral shedding : case report
Publicado: (2022)

Case series with literature review: Surgical approach to megarectum and/or megasigmoid in children with unremitting constipation
por: Glasser, James G., et al.
Publicado: (2017)

Spontaneous Splenic Rupture and Rituximab-Induced Acute Thrombocytopenia in a Patient with High-Risk Mantle Cell Lymphoma
por: Williams, Jared, et al.
Publicado: (2019)

The long-quarantined case of COVID-19 with prolonged viral shedding and intermittent fever for more than 70 days
por: Yamada, Eijiro, et al.
Publicado: (2021)

A multicenter phase II study of bendamustine, rituximab, and cytarabine (BRAC) for relapsed or refractory patients with follicular lymphoma or mantle cell lymphoma
por: Nakamura, Nobuhiko, et al.
Publicado: (2022)

Improvement of the rituximab–induced cell death by potentiation of the store-operated calcium entry in mantle cell lymphoma cell lines
por: Doignon, Isabelle, et al.
Publicado: (2019)

Polatuzumab‐bendamustine‐rituximab as bridge to CD19‐directed CAR T cells in mantle cell lymphoma refractory to ibrutinib and venetoclax
por: Perriello, Vincenzo Maria, et al.
Publicado: (2023)

The persistence of cognitive deficits in remitted and unremitted ADHD: a case for the state-independence of response inhibition
por: McAuley, Tara, et al.
Publicado: (2014)

Telomere length as a predictor of response to Pioglitazone in patients with unremitted depression: a preliminary study
por: Rasgon, N, et al.
Publicado: (2016)

McCune-Albright Syndrome With Unremitting Hyperthyroidism at Early Age: Management Perspective for Early Thyroidectomy
por: Merchant, Nadia, et al.
Publicado: (2019)

Shedding Light on Skin Autoimmunity: More than Just Skin Deep
por: Li, Philip Hei, et al.
Publicado: (2023)

Bendamustine/remdesivir/rituximab: Lymphocytopenia, hypogammaglobulinaemia and rebound viral shedding following drug resistance: case report
Publicado: (2022)

Smoldering mantle cell lymphoma
por: Ye, Haige, et al.
Publicado: (2017)

Final Results of a Phase I/II Trial of the Combination Bendamustine and Rituximab With Temsirolimus (BeRT) in Relapsed Mantle Cell Lymphoma and Follicular Lymphoma
por: Hess, Georg, et al.
Publicado: (2020)

A phase 2 study of rituximab, bendamustine, bortezomib and dexamethasone for first-line treatment of older patients with mantle cell lymphoma
por: Gressin, Rémy, et al.
Publicado: (2019)

Severe CMV Infection after Chemo-Immunotherapy with Dose-Reduced Bendamustine and Rituximab in a Mantle Cell Lymphoma Old Patient
por: Magliano, Gabriele, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_lv4tnpo3qqiocgqejf4e0a2ohg